- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
This webinar will discuss SMART IRB resources (and beyond!) that are available to help IRBs and HRPPs implement single IRB arrangements. We will present and discuss a range of resources for documenting reliance arrangements, getting started as a Reviewing IRB, being an informed Relying Institution, and educating and working with study teams - including how and when to use these resources. Our two
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Heather Watchel, MD from the University of Pennsylvania, hosted by the Harvard Medical School will present her research on “Circulating microRNA Signatures in Primary Hyperparathyroidism.”
Amyotrophic lateral sclerosis (ALS) is a fatal disease that involves progressive death of motor nerves in the brain, brainstem, and spinal cord. The disease is closely related to disorders such as primary lateral sclerosis, hereditary spastic paraplegia, progressive muscular atrophy, and frontotemporal dementia. These diseases have shared genetic causes and underlying biology as well as a shared
Training program: C/T Research Academy Session Dates: July 2021 – May 2023 Application Deadline: January 29, 2021 The goal of the C/T Research Academy is to support, nurture, and grow the next generation of c/t investigators at Harvard Medical School. The program offers advanced training to early-career c/t researchers, with a focus on the core knowledge necessary to achieve success in c/t
The global pandemic caused by SARS-CoV-2 with the attendant morbidity and mortality requires urgent understanding of the natural course of COVID-19 and characterization of the factors of disease severity and poor outcomes. A significant source of data for COVID-19 research is patient data captured in electronic health records (EHRs). To leverage EHRs for COVID-19 research, the national Accrual to